Houston Methodist received FDA approval to transfuse donated plasma from a recovered COVID-19 patient into a critically ill patient. This treatment was fast-tracked to the bedside as the death toll in the COVID-19 pandemic soared to more than 2,000 people across the U.S. Houston Methodist physician scientists began recruiting blood plasma donors on Friday, March 27th from among the approximately 250 patients who have tested positive for the COVID-19 virus at Houston Methodist hospitals. Plas...